15
Views
0
CrossRef citations to date
0
Altmetric
Biotechnology & Immunology

Overview: Bacterial Lipoproteins as Vaccines Candidates and Patent Considerations

&
Pages 669-680 | Published online: 02 Mar 2011

References to Primary Literature

  • Lex, AW Wiesmuller, KH Jung, G Bessler, WG A synthetic analogue of Escherichia coli lipoprotein, tripalmitol pentapeptide, constitutes a potent immune adjuvant. J. Immunol. 1986 137 2676–2681.
  • Brandt, ME Riley, BS Radolf, JD Norgard, MV Immunogenic integral membrane proteins of Borrelia burgdorfi are lipoproteins. Infect. Immun. 1990 58 983–991.
  • Chamberlin, NR Brandt, ME Erwin, AL Radolf, JD Norgard, MV Major integral membrane protein immunogens of Treponema pallidum are proteolipids. Infect. Immun. 1989 57 2872–2877.
  • Chen, C Parsons, CS Morse, SA Membrane proteolipids of Neisseria gonorrhoeae The Pathogenic Nesseriae. Schoolnik, G American Society for Microbiology Washington, DC 1988.
  • Weinberg, GA Twoler, DA Munson, RS Jr Lipoproteins of Haemophilus influenzae type b. J. Bacteriol. 1988 170 4161–4164.
  • Hantke, BraunV Covalent binding of lipid to protein. Eur. J. Biochem. 1973 34 284–296.
  • Mizuno, T Structure of the peptidoglycan-associated lipoprotein (PAL) of the Proteus mirabilis outer membrane. II. Sequence of the amino terminal part of the peptidoglycan-associated lipoprotein. J. Biochem. (Tokyo) 1981 89 1059–1066.
  • Braun, V Sieglin, U Sequence of the murein lipoprotein and the attachment site of the lipid. Eur. J. Biochem. 1970 28 51–69.
  • Inouye, M Shaw, J Shen, C The assembly of a structural lipoprotein in the envelope of Escherichia coli. J. Biol. Chem. 1972 247 8154–8159.
  • Gomez-Miguel, MJ Moriyon, I Demonstration of a peptidoglycan-linked lipoprotein and characterization of its trypsin fragment in the outer membrane of Brucella spp. Infect. Immun. 1986 53 678–684.
  • Gomez-Miguel, MJ Moriyon, I Lopez, J Brucella outer membrane lipoprotein shares antigenic determinants with Escherichia coli Braun lipoprotein and is exposed on the cell surface. Infect. Immun. 1987 55 258–262.
  • Gomez-Miguel, MJ Moriyon, I Alonso-Urmeneta, B Riezu-Boj, JI Diaz, R Serological response to the outer membrane lipoprotein in animal Brucellosis. Infect. Immun. 1988 56 716–718.
  • Duchene, M Baron, C Schweizer, A von Specht, B-U Domdey, H Pseudomonas aeruginosa outer membrane lipoprotein I gene: Molecular cloning, sequence, and expression in Escherichia coli. J. Bacteriol. 1989 171 4130–4137.
  • Mizuno, T A novel peptidoglycan-associated lipoprotein found in the outer membrane of Proteus mirabilis and other Gram-negative bacteria. J. Biochem. 1981 89 1039–1049.
  • Deich, RA Metcalf, BJ Finn, CW Farley, JE Green, BA Cloning of genes encoding a 15,00-dalton peptidoglycan-associated outer membrane lipoprotein and an antigenically related 15,000-dalton protein from Haemophilus influenzae. J. Bacteriol 1988 170 489–498.
  • Zlotnick, GW Sanfillippo, VT Mattler, JA Kirkley, DH Boykins, RA Seid, RC Jr Purification and characterization of a peptidoglycan-associated lipoprotein from Haemophilus influenzae. J. Biol. Chem. 1988 263 9790–9794.
  • Chen, R Henning, U Nucleotide sequence of the gene for the peptidoglycan-associated lipoprotein of Escherichia coli. Eur. J. Biochem. 1987 163 73–77.
  • Nelson, MB Apicella, MA Murphy, TF Vankeulen, H Spotila, LD Rekosh, D Cloning and sequencing of Haemophilus influenzae outer membrane protein P6. Infect. Immun. 1988 56 128–134.
  • Green, BA Quinn-Dey, T Zlotnick, GW Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influ- enzae type b. Infect. Immun. 1987 55 2878–2883.
  • Green, Ba Metcalf, BJ Quinn-Dey, T Kirkley, DH Quataert, SA Deich, RA A recombinant non-fatty acylated form of the Hi-PAL (P6) protein of Haemophilus influenzae elicits biologically active antibody against both nontypable and type b H. influenzae. Infect. Immun. 1990 58 3272–3278.
  • Deich, RA Anilionis, A Fulginiti, J Metcalf, BJ Quataert, SA Quinn-Dey, T Zlotnick, GW Green, BA Antigenic conservation of the 15,000-dalton outer membrane lipoprotein PCP of Haemophilus influenzae and biologic activity of anti-PCP antisera. Infect. Immun. 1990 58 3388–3393.
  • Baehr, W Gotschlich, EC Hitchcock, P The virulence-associated Neisserial H.8 gene encodes a pentapeptide sequence found in 14 tandem repeats. Mol. Microbiol. 1989 3 49–56.
  • Kawula, TH Spinola, SM Klapper, DG Cannon, JG Localization of a conserved epitope and an azurin-like domain in the H.8 protein of pathogenic Neisseria. Mol. Micmbiol. 1987 1 179–185.
  • Hansen, EB Pedersen, PE Schouls, LM Severin, E van Embden, JDA Genetic characterization and partial sequence determination of a Treponema pallidum operon expressing two immunogenic membrane proteins in Escherichia coli. J. Bacteriol. 1985 162 1227–1237.
  • Swancutt, MA Radolf, JD Norgard, MV The 34-kilodalton membrane immunogen of Treponema pallidum is a lipoprotein: Infect. Immun. 1990 58 384–392.
  • Anderson, BE Regnery, RL Carlone, GM Tzianbos, T McDade, JE Fu, ZY Bellini, WJ Sequence analysis of the 17-kilodalton-antigen gene from Rickettsia rickettsii. J. Bacteriol. 1987 169 2385–2390.
  • Dudler, R Schmidhauser, C Parish, RW Wettenhall, REH Schmidt, T A Mycoplasma high-affinity transport system and the in vitro invasivenes of mouse sarcome cells. EMBO J. 1988 7 3963–3970.
  • Kim, MF Heidari, MB Stull, SJ McIntosh, MA Wise, KS Identification and mapping of an immunogenic region of Mycoplasma hyopneumoniae p65 surface lipoprotein expressed in Escherichia coli from a cloned genomic fragment. Infect. Immun. 1990 58 2637–2643.
  • Wu, HC Tokunaga, M Biogenesis of lipoproteins in bacteria. Curr. Top. Microbiol Immunol. 1986 125 127–157.
  • Hayashi, S Wu, HC Lipoproteins in bacteria. J. Bionerg. and Biomem. 1990 22 451–471.
  • Pugsley, AP Greasy proteins. Microbiol. Sci. 1988 5 153–155.
  • Klein, P Somorjai, RL Lau, PCK Distinctive properties of signal sequences from bacterial lipoproteins. Prot. Eng. 1988 2 15–20.
  • Bluestone, CD Klein, JO Otitis media with effusion, atelectasis, and eustacian tube dysfunction Bluestone, CD, Stool, SE W.B. Saunders Co. Philadelphia 1983 356.
  • Musher, DM Kubitshek, KR Crennan, J Baughn, RE Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann. Intern. Med. 1983 99 344–350.
  • Walker, RJ Jr. Baker, CJ Quinones, FJ Hollis, DG Weaver, RE Wiss, K Nontypable Haemophilus influenzae (biotype 4) as a neonatal, maternal, and genital pathogen. Annu. Rev. Infect. Dis. 1983 5 123–135.
  • Anderson, P Johnston, RB Jr Smith, DH Human serum activities against Haemophilus influenzae type b. J. Clin. Invest. 1972 51 31–38.
  • Murphy, TP Bartos, LC Campagnari, AM Nelson, MB Dudas, KC Apicella, MA Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae. Infect. Immun. 1986 54 774–777.
  • Murphy, TF Nelson, MB Dudas, KC Mylotti, JM Apicella, MA Identification of a specific epitope of Haemophilus influenzae on a 16,600 dalton outer membrane protein. J. Infect. Dis. 1986 152 1300–1307.
  • Munson, RS Jr. Granoff, DM Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b. Infect. Immun. 1985 49 544–549.
  • Murphy, TF Bartos, LC Rice, PA Nelson, MB Dudas, KC Apicella, MA Identification of a 16,600 dalton outer membrane protein on nontypable Haemophilus influenzae as a target for human bactericidal antibody. J. Clin. Invest. 1986 78 1020–1027.
  • Granoff, DM Munson, RS Jr Prospects for prevention of Haemophilus influenzae type b disease by immunisation. J. Infect. Dis. 1986 153 448–461.
  • Hancock, REW Intrinsic antibiotic resistance of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 1986 18 653–659.
  • Pollack, M Pseudomonas aeruginosa Mandell, GL, Douglas, RG Jr, Bennett, JE John Wiley and Sons, Inc. New York 1985 1236–1250.
  • Woods, DE Bryan, LE Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals. J. Infect. Dis. 1985 151 581–588.
  • Pier, GB Safety and immunogenicity of high-molecular weight-polysaccharide vaccine from immunotype I Pseudomonas aeruginosa. J. Clin. Invest. 1982 69 303–308.
  • Cryz, SJ Jr. Furer, E Cross, AS Wegmann, A Germanier, R Sadoff, JC Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans. J. Clin. Invest. 1987 80 51–56.
  • Mutharia, LM Nicas, TI Hancock, REW Outer membrane proteins of Pseudomonas aeruginosa serotype strains. J. Infect. Dis. 1982 146 770–779.
  • Finke, M Duchene, M Eckhardt, A Domdey, H von Specht, B-U Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli. Infect. Immun. 1990 58 2241–2244.
  • Yushkova, NA Kholodkova, EV Korobova, TS Stanislavsky, ES Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein. Acta Micro. Hungarica 1986 33 147–156.
  • Winter, AJ Verstreate, DR Hall, CE Jacobson, RH Castleman, WL Meredith, MP McLaughlin, CA Immune response to porin in cattle immunized with whole cell, outer membrane, and outer membrane protein antigens of Brucella abortus combined with trehalose dimycolate and muramyl dipeptide adjuvants. Infect. Immun. 1983 42 1159–1167.
  • Winter, AJ Jacobson, CE Verstreate, DR Meredith, MP Castleman, WL Effect of pregnancy on the immune response of cattle to a Brucella vaccine. J. Reprod. Immunol. 1986 9 313–325.
  • Dubray, G Charriaut, C Evidence of three major polypeptide species and two major polysaccharide species in the Brucella outer membrane. Ann. Rech. Vet. 1983 14 311–318.
  • Winter, AJ Rowe, GE Comparative immune responses to native cell envelope antigens and the hot sodium dodecyl sulfate insoluble fraction (PG) of Brucella abortus in cattle and mice. Vet. Immunol. Immunopath. 1988 18 149–163.
  • Bosseray, N Plommet, A Plommet, M Third International Symposium on Brucellosis 1984 257–270.
  • Schweinle, JE Hitchcock, PJ Tenner, AJ Hammer, CH Frank, MM Joiner, KA Interaction of Neisseria gonorrhoeae with classical components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen. J. Clin. Invest. 1989 83 397–403.
  • Parsons, NJ Kwaasi, AAA Patel, PV Nairn, CA Smith, H A determinant of resistance of Neisseria gonorrhoeae to killing by human phagocytes: An outer membrane lipoprotein of about 20 kDa with a high content of glutamic acid. J. Gen. Micro. 1986 132 3277–3287.
  • Bergstrom, S Bundox, VG Barbour, AG Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochete Borrelia burgdorfi. Mol. Microbiol. 1989 3 479–486.
  • Swancutt, MA Riley, BS Radolf, JD Norgard, MV Molecular characterization of the pathogen-specific 34-kilodalton membrane immunogen of Treponema pallidum. Infect. Immun. 1989 57 3314–3323.
  • Boyer, MJ Wise, KS Lipid-modified surface protein antigens expressing size variation within the species Mycoplasma hyorhinis. Infect. Immun. 1989 57 245–254.
  • Bricker, TM Boyer, MJ Keith, J Watson-McKown, R Wise, KS Association of lipids with integral membrane surface proteins of Mycoplasma hyorhinis. Infect. Immun. 1988 56 295–301.
  • Rosengarten, R Wise, KS Phenotypic switching in mycoplasmas: Phase variation of diverse surface lipoproteins. Science 1990 247 315–320.
  • Wise, KS Kim, KF Major membrane surface proteins of Mycoplasma hyopneumoniae selectively modified by covalently bound lipid. J. Bacteriol. 1987 169 5546–5555.
  • Freeman, MJ Armstrong, CH Sands-Freeman, LL Lopez-Osuna, M Serological cross-reactivity of porcine reference antisera to Mycoplasma hyopneumoniae, M. flocculare, M. hyorhinis, and M. hyosynoviae indicated by the enzyme-linked immunosorbent assay, complement fixation and indirect hemagglutination test. Can. J. Comp. Med. 1984 48 202–207.
  • Young, TF Ross, RF Assessment of antibody response of swine infected with Mycoplasma hyopneumoniae by immunoblotting. Am. J. Vet. Res. 1987 48 651–656.

References to Patent literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.